A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/36 (2006.01) A61L 27/00 (2006.01) A61L 27/38 (2006.01) A61L 27/60 (2006.01) A61K 35/12 (2006.01) C12N 5/06 (2006.01) C12N 5/08 (2006.01)
Patent
CA 2154368
A process for culturing and generating a chimeric cell culture, in particular chimeric epithelium, is disclosed. The chimeric epithelium oan be used to treat skin trauma such as burn victims. Autologous epithelial grafts have been used on burn patients although this requires that the patient's cells are cultured and expanded in vitro which generally takes four to five weeks. The chimeric epithelium of the present invention is composed of cells that are both autologous and allogeneic to the host. Therefore, the allogeneic cells can be maintained in a cell bank and co--cultured with autologous host cells when needed. This significantly reduces the time required (by up to 50 %) for autologous cell expansion and culture prior to grafting. Furthermore, it has been demonstrated that the allogeneic cells are passively eliminated from the graft without rejection of the total graft.
Auger Francois A.
Germain Lucie
Lafleur Louis
Rouabhia Mahmoud
Smart & Biggar
Universite Laval
LandOfFree
Therapeutic applications of chimeric organogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic applications of chimeric organogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic applications of chimeric organogenesis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1596229